- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04829266
Mental Simulations and Early Mobilization of Patients After Cesarean Section
March 30, 2021 updated by: Anna Prokopowicz, MSc, Wroclaw Medical University
Effect of Mental Simulations on the Early Mobilization of Patients After Cesarean Section
Mental simulations can motivate patients for their first verticalization after cesarean section, although perceived anxiety before verticalization may reduce a positive effect of mental simulations.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Wrocław, Poland, 50-556
- 2nd Chair and Clinic of Gynecology and Obstetrics, Jan Mikulicz-Radecki University Teaching Hospital in Wrocław, Wrocław, Poland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- must be qualified to and undergoing delivery using Cesarean section,
- must be undergoing conduction of anesthesia during Cesarean section,
- must be undergoing the analgesic therapy in the postoperative period,
- must be qualified to mobilization by the medical staff,
- must be fluent in Polish in speaking and writing.
Exclusion Criteria:
- any orthopedic dysfunction,
- any neurological dysfunction,
- any psychiatric disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: process simulation group
an experimental group with process simulation with elements of relaxation
|
Audio recordings with a mental simulation.
The women listened to the text using headphones about 10-15 min before verticalization (5 h after arrival in the postoperative room, about 6 h after anesthesia).
In each group, the mental training lasted for about 10 min.
Other Names:
|
|
Experimental: outcome simulation group
an experimental group with outcome simulation with elements of relaxation
|
Audio recordings with a mental simulation.
The women listened to the text using headphones about 10-15 min before verticalization (5 h after arrival in the postoperative room, about 6 h after anesthesia).
In each group, the mental training lasted for about 10 min.
Other Names:
|
|
Other: control group
a control group with no process and outcome simulations, but with elements of relaxation
|
Audio recordings with a mental simulation.
The women listened to the text using headphones about 10-15 min before verticalization (5 h after arrival in the postoperative room, about 6 h after anesthesia).
In each group, the mental training lasted for about 10 min.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
willingness to verticalize
Time Frame: Immediately after a single mental simulation
|
Percentage of women who were willing to verticalize after listening to the recording.
Assessed on a on a six-point scale.
|
Immediately after a single mental simulation
|
|
verticalization
Time Frame: Immediately after a single mental simulation
|
Percentage of the success of verticalization after listening to the recording.
|
Immediately after a single mental simulation
|
|
duration of the first mobilization
Time Frame: Immediately after a single mental simulation
|
Time form the start of the measurement was set at getting out of bed from a sitting position, and the end of the measurement was set at the patient's return to bed.
|
Immediately after a single mental simulation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain level
Time Frame: 3 time points (before and immediately after a single mental simulation, and immediately after verticalization.
|
The average pain she experienced during upright standing.
Measured with a 10-point numerical rating scale.
|
3 time points (before and immediately after a single mental simulation, and immediately after verticalization.
|
|
anxiety
Time Frame: upon arrival at the recovery room, before and immediately after a single mental simulation.
|
Measured with a 10-point numerical rating scale.
|
upon arrival at the recovery room, before and immediately after a single mental simulation.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anna Prokopowicz, Department of Applied Obstetrics, Faculty of Health Sciences, Wroclaw Medical University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 15, 2017
Primary Completion (Actual)
May 27, 2018
Study Completion (Actual)
May 27, 2018
Study Registration Dates
First Submitted
March 23, 2021
First Submitted That Met QC Criteria
March 30, 2021
First Posted (Actual)
April 2, 2021
Study Record Updates
Last Update Posted (Actual)
April 2, 2021
Last Update Submitted That Met QC Criteria
March 30, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 05P/12-2017
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.